Drugs / STAT3 decoy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00696176 | Aug 2008 → Aug 2011 | head and neck cancer | University of Pittsburgh | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STAT3 decoy | “First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.” PMID 22719020 ↗ Jun 2012 |
| Action | Inhibit | “inhibit tumor STAT3 signaling” PMID 22719020 ↗ Jun 2012 |
| Modality | Oligonucleotide (other) | “STAT3 decoy oligonucleotide” PMID 22719020 ↗ Jun 2012 |
| Route | Other | “single dose of intratumoral STAT3 decoy” NCT00696176 ↗ |
| Target | STAT3 | “We developed a decoy targeting STAT3 and conducted a phase 0 trial.” PMID 22719020 ↗ Jun 2012 |